Abstract
To assess potential health risks of nanoparticles by means of in vitro or in vivo assays and to determine dose-action curves a defined and reproducible method of particle administration is required. The interpretation of the toxicological results should be based on a comprehensive chemical-physical characterization of the particles used. Therefore, we developed a method to suspend nanoparticles stably and homogenously in physiological media. Our approach consist of three steps: (1) physical-chemical characterisation of the powders as delivered, (2) preparation and characterization of a non-physiological electro-statically stabilized nanoparticle suspension and (3) assessment of the nanoparticles behaviour in physiological media with or without proteins. This approach is demonstrated on a titanium dioxide and a tungsten carbide nanopowder. Results showed that particles agglomerate in protein-free medium within minutes, whereas in the presence of bovine serum albumin or foetal bovine serum an agglomeration is hindered.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.